Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CFO Fawwad Qureshi sold 1,373 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the transaction, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. The trade was a 36.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Fawwad Qureshi also recently made the following trade(s):
- On Friday, November 29th, Fawwad Qureshi sold 9,867 shares of Trupanion stock. The shares were sold at an average price of $53.08, for a total value of $523,740.36.
Trupanion Stock Performance
Shares of NASDAQ TRUP traded down $2.14 during midday trading on Monday, hitting $32.40. 1,449,904 shares of the company's stock were exchanged, compared to its average volume of 675,532. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a market cap of $1.37 billion, a P/E ratio of -140.87, a PEG ratio of 6.02 and a beta of 1.60. The stock's 50 day moving average price is $45.87 and its 200-day moving average price is $47.89.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Equities research analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Hedge Funds Weigh In On Trupanion
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC lifted its stake in shares of Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the period. Barclays PLC raised its holdings in Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after purchasing an additional 47,262 shares in the last quarter. Centiva Capital LP acquired a new stake in Trupanion in the third quarter worth approximately $595,000. FORA Capital LLC acquired a new stake in Trupanion in the third quarter worth approximately $540,000. Finally, Blueshift Asset Management LLC boosted its stake in Trupanion by 215.8% during the 3rd quarter. Blueshift Asset Management LLC now owns 37,230 shares of the financial services provider's stock valued at $1,563,000 after purchasing an additional 25,440 shares in the last quarter.
Analyst Ratings Changes
Several brokerages recently issued reports on TRUP. Stifel Nicolaus cut their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Piper Sandler dropped their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $46.60.
Check Out Our Latest Research Report on TRUP
Trupanion Company Profile
(
Get Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
